Flow cytometric analysis of HaCaT (Human skin keratinocyte, left) / NCCIT (Human pluripotent embryonic carcinoma epithelial cell, right) labelling Podoplanin antibody at 1/2000 dilution (0.1 μg) / (red) compared with a Rat monoclonal IgG (black) Isotype Control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat Anti - Rat IgG Alexa Fluor® 647 was used as the secondary antibody.
Negative control: HaCaT
Product Details
Product Details
Product Specification
| Host | Rat |
| Antigen | Podoplanin |
| Synonyms | Aggrus; Glycoprotein 36 (Gp36); PA2.26 antigen; T1-alpha (T1A); GP36; PDPN |
| Location | Membrane |
| Accession | Q86YL7 |
| Clone Number | S-2796 |
| Antibody Type | Rat mAb |
| Application | FCM |
| Reactivity | Hu |
| Positive Sample | NCCIT |
| Purification | Protein G |
| Concentration | 2 mg/ml |
| Conjugation | Unconjugated |
| Physical Appearance | Liquid |
| Storage Buffer | PBS pH7.4 |
| Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied |
Dilution
| application | dilution | species |
| FCM | 1:2000 | Hu |
Background
Podoplanin is a small mucin-type O-glycosylated type-I transmembrane protein of 162 amino acids, highly expressed on lymphatic endothelium, alveolar type I cells, tumor cells and brain neurons, where its extracellular domain—bearing the platelet-aggregation-stimulating PLAG motif and sialylated O-glycans—engages CLEC-2 on platelets to trigger platelet activation, binds CD44 and galectin-8 to promote directional cell migration and invadopodia maturation, associates with ERM proteins (ezrin-radixin-moesin) to reorganize the actin cytoskeleton and drive epithelial-mesenchymal transition, and is indispensable for developmental separation of blood and lymphatic vessels, normal alveolus formation, lymphatic vessel integrity and hippocampus-dependent synaptic plasticity and memory, while its overexpression in cancers fosters invasion, metastasis and thrombotic risk, making it a key diagnostic and therapeutic target.
Picture
Picture
FC
